CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. (CNBX)

About CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. (CNBX)

CNBX Pharmaceuticals, Inc. is a clinical stage company, which engages in the discovery, development, and commercialization of cannabinoid-based products and technologies for the treatment of cancer. Its products include Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome (CACS), and RCC-33, an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC). The company was founded by Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.

CNBX PHARMACEUTICAL INC by CNBX Pharmaceuticals Inc. News